Das George-Huntington-Institut
GHI rekrutiert für die HDClarity Studie
June 19, 2018

Das GHI sucht Teilnehmer an der HDClarity Studie!

Die HDClarity Studie der CHDI...

Read More
Dr. Reilmann und Dr. Bonnie Hennig-Trestman für die Wahl zum Chair/Co-Chair der "Huntington Study Group" nominiert
February 1, 2018

Dr. Ralf Reilmann und Dr. Bonnie Hennig-Trestman wurden als Kandidaten für die Chair/Co-Chair...

Read More
Dr. Reilmann speaks 3rd Taiwan International Congress of PD and Movement Disorders
January 15, 2018

Dr. Reilmann speaking about research news and therapeutic strategies in HD at the 3rd Taiwan...

Read More
Ionis Study: mutated Huntingtin was lowered successfully in CSF of Huntington patients
December 11, 2017

The HD community learns that a phase I/II study of Ionis Pharmaceuticals showed a...

Read More
Interview with Dr. Reilmann by European Huntington Association
December 5, 2017

Astri Arnesen, Chair of the European Huntington Association, interviewed Dr. Reilmann at the...

Read More
Dr. Reilmann moderating global CME program for HD
December 5, 2017

Dr. Reilmann moderated a discussion of HD experts Claudia Testa (Richmond, VA, USA), Bernhard...

Read More
Huntington Symposium on German Parkinson and Movement Disorders Meeting in Baden Baden
May 12, 2017

THe annual meeting of the German Parkinson and Movement Disorders Society hosted a special...

Read More
Hddennomore - HD community hosted by Pope Franciscus in the Vatican
September 26, 2016

On May 18, 2017, Pope Franciscus hosts a special audience for the HD community at the...

Read More
Dr Reilmann at the Huntington Study group meeting in the US
October 20, 2015

Dr Reilmann took place at the annual Huntington Study Group (HSG) meeting in Tampa, Florida....

Read More
Dr. Reilmann as Co-Chair of MDS-Task Force referred about diagnosis criteria of HD
October 20, 2015

On the initiative of Dr Reilmann and professor Christopher Ross from the Hopkins University...

Read More
Roche Studie Generation-HD1 stoppt weitere Dosierung
March 22, 2021

Die Firma Roche hat in einer Pressemeldung mitgeteilt, dass die Generation-HD1 Studie mit dem...

Read More
PROOF-HD phase III pivotal trial with Pridopidine
September 30, 2020

GHI will shortly start the pivotal phase III trial PROOF-HD with Pridopidine. Several studies...

Read More
SHIELD-HD Study of Triplet Therapeutics started at GHI
September 24, 2020

nan

Read More
Erreichbarkeit während der Umzugsphase
June 22, 2020

Liebe Patienten, Angehörige und Interessenten,

 

aufgrund des Umzugs sind die...

Read More
IDEA-FAST consortium receives € 44 Mio. from EU IMI2/Horizon 2020 program - GHI partner
December 6, 2019

The IMI2 consortium IDEA-FAST receives € 44 Mio. funding in the Horizon 2020 programm of the...

Read More